Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...

Argentina’s award-winning mare Polo Pureza will have her genes, or at least most of them, live on in five genetically edited horses designed to outrun the polo legend herself.Scientists at Argentine ...

Variant Bio recently announced a multimillion-dollar deal with a pharmaceutical company, and some of that money will go to ...

SARANAC LAKE — Local research and biotechnology laboratories Trudeau Institute and Ampersand Biosciences have received a $1 million grant to produce tools aiding the research of the flu.

Comedian and actor Kheiron unveils his first play, Alba et Sadaf, an intriguing and daring creation. Now playing at the Théâtre des Mathurins, the play tells the true stories of two women living ...

The Iowa State University Extension and Outreach Farm, Food, and Enterprise Development program prepares the annual report, which provides a snapshot of the Iowa craft beer industry from the monthly ...

They show that he plans to divest stock holdings, including stakes in biotech firms CRISPR Therapeutics AG and Dragonfly Therapeutics. He’s also stepping down from roles at his law firm and at ...

A requisite majority of H-class shareholders did not approve the buyout, the companies said. "The proposed privatisation of the Company (Henlius) will not proceed and the listing of the H Shares ...

Primarily, Ascentage hopes to leverage the IPO proceeds to advance its pipeline. Around $50 million to $60 million, for instance, will help the biotech pursue approval for its BCL-2 blocker ...

The biotech firm's mRNA-1018 candidate posted positive results in a Phase 1/2 study launched in 2023. Moderna plans to move mRNA-1018 to a Phase 3 trial. Shares of Moderna (MRNA) took off Tuesday ...